CERo Therapeutics Holdings, Inc. logo

CEROCERo Therapeutics Holdings, Inc.

CERO Stock Price, Valuation & Chart | CERo Therapeutics Holdings, Inc.

Compare

CERO Historical price chart

CERO Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization712.78K
PE Ratio0.0
EPS-71.76
Trading Volume1.08M
Today's High/Low0.02/0.01
Dividend Yield0.00
52 Week High/Low7.6/0.01
Shares Outstanding45.11M
CERO Financial Statement
CERO Analyst ratings
CERO Analysis & performance metrics

CERO Company profile

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead…

CERO Management team

Management
Andrew Albert Kucharchuk M.B.A.CFO
Chief Financial Officer
Kristen Pierce Ph.D.
Chief Development Officer
Lawrence Corey M.D.
Co-founder & Head of Scientific Advisory Board
Christopher B. Ehrlich M.B.A.CEO
Chief Executive Officer & Chair
Total 4 executives

CERO Frequently asked questions

What is CERo Therapeutics Holdings, Inc. (CERO) Stock Price?

Current stock price of CERo Therapeutics Holdings, Inc. (CERO) stock is $0.020. The stock price is +31.67% higher in the session. The intraday range can be seen from this page. Volume of CERo Therapeutics Holdings, Inc. (CERO) stock is 1.08M.

Last updated at 02 Sept 2026, 07:59 pm.

Why is the CERo Therapeutics Holdings, Inc. (CERO) stock price going up or down today?

The stock price of CERo Therapeutics Holdings, Inc. (CERO) can change with earnings, company news, and overall market sentiment. CERo Therapeutics Holdings, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the CERo Therapeutics Holdings, Inc. stock expensive at its current price?

Whether CERo Therapeutics Holdings, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CERO on this page is 0.00. EPS on this page is -71.76. Compare those figures with peers and growth expectations before deciding if the current CERo Therapeutics Holdings, Inc. price is justified.

How has the stock price of CERo Therapeutics Holdings, Inc. (CERO) performed historically?

Historical performance for CERo Therapeutics Holdings, Inc. (CERO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CERO reacted to past earnings and market events.

Should I buy CERo Therapeutics Holdings, Inc. (CERO) stock, at this price?

Buying CERo Therapeutics Holdings, Inc. (CERO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.